Cargando…

Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review

Hepatitis C (HCV) infection has an estimated global prevalence of 2.5%, causing chronic liver disease in 170 million people worldwide. Recent data has identified HCV infection as a risk factor for subclinical and clinical cardiovascular disease (CVD), but these data have been mixed and whether HCV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babiker, Ahmed, Jeudy, Jean, Kligerman, Seth, Khambaty, Miriam, Shah, Anoop, Bagchi, Shashwatee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719192/ https://www.ncbi.nlm.nih.gov/pubmed/29226101 http://dx.doi.org/10.14218/JCTH.2017.00021

Ejemplares similares

Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
por: Babiker, Ahmed, et al.
Publicado: (2019)

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease
por: Freeman, Michael L, et al.
Publicado: (2023)

Association of hepatitis C infection and acute coronary syndrome: A case-control study
por: Wu, Angela, et al.
Publicado: (2021)

Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
por: Lee, Kuan Ken, et al.
Publicado: (2019)

Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population
por: Bagchi, Shashwatee, et al.
Publicado: (2017)

Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019)

Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities
por: Kligerman, Seth, et al.
Publicado: (2021)

CT on the Diamond Princess: What Might This Tell Us About Sensitivity for COVID-19?
por: Isikbay, Masis, et al.
Publicado: (2020)

Peritonitis due to Candida albicans in a Patient with Chronic Hepatitis C Infection
por: Chakravarty-Vartak, Urmi S., et al.
Publicado: (2008)

Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis
por: Maggi, Paolo, et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C
por: Kamar, Fareed B., et al.
Publicado: (2016)

Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk
por: Jarcuska, Peter, et al.
Publicado: (2018)

Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System
por: Biomy, Reda, et al.
Publicado: (2017)

Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana’a, Yemen
por: Murad, Entisar A, et al.
Publicado: (2013)

Comparison of hepatic and splenic stiffness in chronic hepatitis C infection with and without schistosomal infection; correlation with hepatic histopathological changes
por: Gohary, Ahmed Al, et al.
Publicado: (2020)

Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C
por: Poliwczak, Adam R., et al.
Publicado: (2020)

Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Ramadan, Mohammad Said, et al.
Publicado: (2022)

Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study
por: Agarwal, S. K., et al.
Publicado: (2016)

2253. Comparison of Cardiovascular Risk in Patients Infected With HIV and Hepatitis C
por: Ma, Jimmy, et al.
Publicado: (2018)

Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies
por: Poller, Wolfgang, et al.
Publicado: (2018)

Deep Learning Localization of Pneumonia: 2019 Coronavirus (COVID-19) Outbreak
por: Hurt, Brian, et al.
Publicado: (2020)

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
por: Sugiura, Ayumi, et al.
Publicado: (2017)

Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease
por: Kim, Victor, et al.
Publicado: (2021)

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
por: Drazilova, Sylvia, et al.
Publicado: (2018)

The Role of Multimodality Imaging in HIV-Associated Cardiomyopathy
por: Gambahaya, Ellise T., et al.
Publicado: (2022)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Acute Lung Infections in Normal and Immunocompromised Hosts
por: Waite, Stephen, et al.
Publicado: (2006)

Role of T-Helper 9 Cells in Chronic Hepatitis C-Infected Patients
por: Ali, Mohamed E., et al.
Publicado: (2018)

Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: a prospective study
por: Refky, Basel, et al.
Publicado: (2015)

Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis
por: Jain, Ayushi, et al.
Publicado: (2022)

Cardiometabolic risk factors among HIV patients on antiretroviral therapy
por: Kiage, James N, et al.
Publicado: (2013)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Changing Epidemiological Patterns of Infection and Mortality Due to Hepatitis C Virus in Poland
por: Genowska, Agnieszka, et al.
Publicado: (2023)

Fulminant hepatic failure (FHF) due to acute hepatitis C
por: Younis, Bilal Bin, et al.
Publicado: (2015)

Cardiovascular Risk Management and Hepatitis C: Combining Drugs
por: Smolders, Elise J., et al.
Publicado: (2018)

Segmental Difference of the Hepatic Fibrosis from Chronic Viral Hepatitis due to Hepatitis B versus C Virus Infection: Comparison Using Dual Contrast Material-Enhanced MRI
por: Shim, Jae Ho, et al.
Publicado: (2011)

The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia
por: El-Shamy, Ahmed, et al.
Publicado: (2018)

Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil
por: Vigani, Aline G, et al.
Publicado: (2008)

Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
por: Tamayo, Aracely, et al.
Publicado: (2016)

The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
por: Kang, Jin Gu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4acs9in80h3s5o6qalm0r7r9et